Clinical Trial Update: Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism [Phase 2]

View source ↗

Summary

A Phase IIa study evaluated fomepizole for acetaldehyde toxicity after ethanol exposure in individuals with ALDH2 deficiency, with results posted after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldehyde Dehydrogenase-2 Deficiency

Drugs mentioned

• Fomepizole (Antizol) (fomepizole)

Snippet

Sponsor: Amgen | Conditions: Aldehyde Dehydrogenase-2 (ALDH2) Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2017-09-15